Martins Diana, Pires Sara, Pimentel-Nunes Pedro, Almeida Silva Rui, Dias Claúdia Camila, Dinis-Ribeiro Mário
Gastroenterology Department, Tondela-Viseu Hospital Center, Viseu, Portugal.
Gastroenterology Department, Espirito Santo Hospital, Évora, Portugal.
GE Port J Gastroenterol. 2018 Nov;25(6):291-298. doi: 10.1159/000486608. Epub 2018 Feb 8.
BACKGROUND/AIMS: Dysphagia due to benign pharyngoesophageal strictures (PES) often requires repeated dilations; however, a uniform definition for the therapeutic efficacy of this technique has not been yet established. We aimed to assess the overall efficacy of endoscopic dilation of pharyngoesophageal anastomotic or post-radiotherapy (post-RT) strictures.
The data of 48 patients with post-RT ( = 29) or anastomotic PES ( = 19) submitted to endoscopic dilation during a 3-year period were retrospectively assessed. The Kochman criteria were used to determine refractoriness and recurrence. Patients were asked to answer a questionnaire determining prospectively the dilation program efficacy as (a) dysphagia improvement, (b) dysphagia resolution, (c) need for further dilations, or (d) percutaneous endoscopic gastrostomy (PEG) during the previous 6 months. Need for additional therapy was considered an inefficacy criterion.
The median number of dilations per patient was 4 (total of 296 dilations) with a median follow-up of 29 months. The mean predilation dysphagia Mellow-Pinkas score was 3 and the initial stenosis diameter was 7 mm. Fifteen and 29% of patients presented with the Kochman criteria for refractory and recurrent strictures, respectively. Moreover, 96 and 60% showed dysphagia improvement and resolution, respectively. Seventy-five-percent did not require dilations during 6 months, and 89% did not require PEG. From the patients' perspective, overall efficacy was achieved in 58% of cases. Nine additional therapies were required. Number of dilations (OR 0.7), stricture diameter (OR 2.2), and nonrecurrence criteria (OR 14.2) appeared as significant predictors of overall efficacy, whereas refractory stenosis criteria did not.
Endoscopic dilation seems to be effective for patients with dysphagia after RT or surgery, especially when assessed as patient perception of improvement. Narrow strictures, recurrent ones, and strictures requiring a higher number of dilations may predict worse outcomes.
Health professionals should establish well-defined efficacy criteria for dilations and base their decision beyond exclusively objective measurements.
背景/目的:良性咽喉食管狭窄(PES)所致吞咽困难通常需要反复扩张;然而,该技术治疗效果的统一标准尚未确立。我们旨在评估内镜下扩张治疗咽喉食管吻合口狭窄或放疗后(RT)狭窄的总体疗效。
回顾性评估48例在3年期间接受内镜下扩张治疗的放疗后(n = 29)或吻合口PES(n = 19)患者的数据。采用科克曼标准确定难治性和复发性狭窄。要求患者回答一份问卷,前瞻性地确定扩张治疗方案的疗效,包括(a)吞咽困难改善情况、(b)吞咽困难缓解情况、(c)是否需要进一步扩张,或(d)过去6个月内是否行胃造口术(PEG)。需要额外治疗被视为无效标准。
每位患者的扩张次数中位数为4次(共296次扩张),中位随访时间为29个月。扩张前吞咽困难的平均梅洛 - 平卡斯评分为3分,初始狭窄直径为7 mm。分别有15%和29%的患者符合科克曼难治性和复发性狭窄标准。此外,分别有96%和60%的患者吞咽困难得到改善和缓解。75%的患者在6个月内不需要扩张,89%的患者不需要行PEG。从患者角度看,58%的病例取得了总体疗效。需要9次额外治疗。扩张次数(比值比0.7)、狭窄直径(比值比2.2)和无复发标准(比值比14.2)似乎是总体疗效的显著预测因素,而难治性狭窄标准则不是。
内镜下扩张对放疗或手术后吞咽困难的患者似乎有效,尤其是从患者对改善情况的感知来评估时。狭窄较窄、复发性狭窄以及需要更多次扩张的狭窄可能预示预后较差。
卫生专业人员应制定明确的扩张疗效标准,并在决策时不仅仅基于客观测量。